Ian Brindle - Covalon Technologies Director

CVALF Stock  USD 0.77  0.03  3.75%   

Director

Dr. Ian Brindle is an Independent Director of Covalon Technologies Ltd., with effect from 16 June 2014. Dr. Brindle is the former Vice President of Research, former Dean of Chemistry and has held other academic postings at Brock University since 1968 since 2014.
Tenure 10 years
Phone905 568 8400
Webhttps://www.covalon.com
Brindle is a professor of Chemistry, holds a Chancellor’s Chair in Research Excellence, is a fellow of the Royal Society of Chemistry and is author of more than 70 publications in analytical chemistry. The University of Manchester awarded Dr. Brindle the degree of Doctor of Science for belonging to that group of scientists who “have distinguished themselves as authorities in the field by their substantial and original contributions to the advancement of knowledge.” He also holds a BS from Manchester University and a Masters of Science from Brock University.

Covalon Technologies Management Efficiency

The company has return on total asset (ROA) of (0.161) % which means that it has lost $0.161 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3213) %, meaning that it generated substantial loss on money invested by shareholders. Covalon Technologies' management efficiency ratios could be used to measure how well Covalon Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.25 M in total debt with debt to equity ratio (D/E) of 0.08, which may suggest the company is not taking enough advantage from borrowing. Covalon Technologies has a current ratio of 9.84, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Covalon Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Covalon Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Covalon Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Covalon to invest in growth at high rates of return. When we think about Covalon Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

William RingoJourney Medical Corp
72
Gene BennettChina Pharma Holdings
66
Katsuhiko MachidaShionogi Co
71
Scott LLBLucy Scientific Discovery
54
Dennis WingerPacira Pharmaceuticals
68
Emmanuel CaeymaexJourney Medical Corp
46
Heung TsuiChina Pharma Holdings
56
Paul HastingsPacira Pharmaceuticals
58
Yvonne GreenstreetPacira Pharmaceuticals
55
Frederick CravesJourney Medical Corp
72
Matthew FustJourney Medical Corp
53
David CohenJourney Medical Corp
53
Mark McDadeJourney Medical Corp
62
Andreas WickiPacira Pharmaceuticals
59
Kenji MatsuoShionogi Co
N/A
Keiichi AndoShionogi Co
66
Teppei MogiShionogi Co
59
Gary PacePacira Pharmaceuticals
70
Akio NomuraShionogi Co
82
Mark KronenfeldPacira Pharmaceuticals
63
Mark FroimsonPacira Pharmaceuticals
57
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. Covalon Tech operates under Biotechnology classification in the United States and is traded on OTC Exchange. Covalon Technologies [CVALF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Covalon Technologies Leadership Team

Elected by the shareholders, the Covalon Technologies' board of directors comprises two types of representatives: Covalon Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Covalon. The board's role is to monitor Covalon Technologies' management team and ensure that shareholders' interests are well served. Covalon Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Covalon Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Elinor Caplan, Director
Murray Miller, Independent Director
Simon Smith, Chief Ltd
John Hands, Sr. Director of Global Marketing
Kim Crooks, VP of Operations
Ron Hebert, VP Marketing
Gale Pollock, Director
Greg Leszczynski, VP HR
Jeffrey Mandel, Independent Director
Hamed Abbasian, VP Devel
Ian Brindle, Director
Elaine Zhang, VP Operations
Myrna Francis, Independent Director
Mark Doolittle, VP Sales
Joseph Cordiano, Independent Director
Valerio DiTizio, Co-Founder and Chief Science Officer
Ronald Smith, Director
Danny Brannagan, CFO
Brian Pedlar, CEO and President and Director
John Suk, Director
Gerry Arambula, Pres Ltd
Jason Gorel, Interim Officer
Abe Schwartz, Chairman of The Board, Advisor and Member of Audit Committee
Martin Bernholtz, Independent Director

Covalon Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Covalon Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Covalon Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Covalon Technologies' short interest history, or implied volatility extrapolated from Covalon Technologies options trading.

Pair Trading with Covalon Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Covalon Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Covalon Technologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Covalon OTC Stock

  0.7TLKMF Telkom Indonesia TbkPairCorr
  0.65TLK Telkom Indonesia Tbk Earnings Call This WeekPairCorr

Moving against Covalon OTC Stock

  0.66AA Alcoa Corp Financial Report 17th of July 2024 PairCorr
  0.6PTITF PT Indosat TbkPairCorr
  0.55XOM Exxon Mobil Corp Financial Report 26th of July 2024 PairCorr
  0.5BAC Bank of America Financial Report 16th of July 2024 PairCorr
The ability to find closely correlated positions to Covalon Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Covalon Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Covalon Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Covalon Technologies to buy it.
The correlation of Covalon Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Covalon Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Covalon Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Covalon Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Covalon Technologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Covalon OTC Stock analysis

When running Covalon Technologies' price analysis, check to measure Covalon Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Covalon Technologies is operating at the current time. Most of Covalon Technologies' value examination focuses on studying past and present price action to predict the probability of Covalon Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Covalon Technologies' price. Additionally, you may evaluate how the addition of Covalon Technologies to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Please note, there is a significant difference between Covalon Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Covalon Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Covalon Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.